1.
|
Phase: Phase III Type: Health services research, Screening Status: Active Age: 45 to 65 Sponsor: Other Protocol IDs: CDC-NCCDPHP-2504, NCT00207636
|
|
2.
|
Phase: Phase III Type: Behavioral study, Health services research, Screening Status: Active Age: 50 to 74 Sponsor: NCI Protocol IDs: TJUH-2006-44, 2006-44, NCT00617071
|
|
3.
|
Phase: Phase III Type: Screening Status: Active Age: 50 to 79 Sponsor: NCI Protocol IDs: TJUH-RSGT-08-017-01-CPPB, RSGT-08-017-01-CPPB, 08G.89, NCT00893295
|
|
4.
|
Phase: Phase III Type: Screening Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 112024, NCT00937950
|
|
5.
|
Phase: Phase III Type: Educational/Counseling/Training, Screening Status: Active Age: 18 to 64 Sponsor: NCI, Other Protocol IDs: P01CA109091-01A1, NCT00760721
|
|
6.
|
Phase: Phase III Type: Screening Status: Active Age: 28 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 113617, NCT01190176
|
|
7.
|
Phase: Phase III Type: Diagnostic, Screening Status: Active Age: 40 and over Sponsor: Other Protocol IDs: FMSU2011-003A, NCT01542814
|
|
8.
|
Phase: Phase III Type: Screening Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: 5130003, LLUMCGI2013, NCT01782014
|
|
9.
|
Phase: Phase II, Phase I Type: Screening Status: Active Age: 40 to 80 Sponsor: NIDDK Protocol IDs: 080173, 08-DK-0173, NCT00719641
|
|
10.
|
Phase: Phase II, Phase I Type: Diagnostic, Screening Status: Active Age: 18 to 80 Sponsor: NCI Protocol IDs: VAMC-WA-33141, 33141, NCT00903136
|
|
11.
|
Phase: Phase II Type: Screening Status: Active Age: 50 to 70 Sponsor: NCI Protocol IDs: LLNL-05-104, NCT00354497
|
|
12.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Screening Status: Active Age: 50 to 80 Sponsor: NCI Protocol IDs: NCCTG-GLNE010, GLNE 010, GLNE010, NCT01511653
|
|
13.
|
Phase: Phase II Type: Health services research, Screening Status: Active Age: 50 to 120 Sponsor: Other Protocol IDs: Oncimmune-2550, NCT01700257
|
|
14.
|
Phase: Phase I Type: Screening Status: Active Age: 45 to 80 Sponsor: Other Protocol IDs: 633, NCT00124163
|
|
15.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Screening Status: Active Age: 25 to 80 Sponsor: Other Protocol IDs: P50CA83636-01, 6973, NCT01121640
|
|
16.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Screening Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: NU 99G8, P30CA060553, NCI-G00-1753, NU-99G7, NCT00005095
|
|
17.
|
Phase: No phase specified Type: Screening Status: Active Age: 30 and over Sponsor: NCI, Other Protocol IDs: CDR0000069397, MGH-000084, NCT00039559
|
|
18.
|
Phase: No phase specified Type: Screening Status: Active Age: Any age Sponsor: NCI Protocol IDs: NCI-01-DC-0099, NCT00045071
|
|
19.
|
Phase: No phase specified Type: Screening Status: Active Age: Any age Sponsor: NCI Protocol IDs: NCI-02-C-0313, NCT00049621
|
|
20.
|
Phase: No phase specified Type: Screening Status: Active Age: 45 to 80 Sponsor: Other Protocol IDs: DAMD17-03-1-0447, NCT00117663
|
|
21.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Diagnostic, Screening Status: Active Age: Over 50 Sponsor: Other Protocol IDs: CDR0000456198, NYU-H-8896-06-B, NCT00301119
|
|
22.
|
Phase: No phase specified Type: Screening Status: Active Age: 50 to 75 Sponsor: NCI, Other Protocol IDs: 5 R01 HS013912-03, NCT00251862
|
|
23.
|
Phase: No phase specified Type: Natural history/Epidemiology, Screening Status: Active Age: 50 and over Sponsor: NCI, Other Protocol IDs: CASE1105, P30CA043703, NCT00445445
|
|
24.
|
Phase: No phase specified Type: Behavioral study, Health services research, Screening Status: Active Age: 50 and over Sponsor: NCI Protocol IDs: FCCC-05016, 05-016, FCCC-IRB-05-016, NCT00459030
|
|
25.
|
Phase: No phase specified Type: Educational/Counseling/Training, Screening Status: Active Age: 50 and over Sponsor: Other Protocol IDs: 070504, NCT00534053
|